Disrupt Therapeutics
PrivateLast Round
Grant
Dec 19, 2025
Total Funding Raised
$538,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Disrupt Therapeutics is a biotechnology company that is developing DRT-101, a peptide-based drug for the treatment of cannabis use disorder (CUD).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Disrupt Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Disrupt Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 19, 2025 | ||||
| Grant | Oct 15, 2024 | ||||
| VC Round | Jan 1, 2024 | ||||
| Accelerator | Nov 1, 2023 | ||||
| Grant | Sep 28, 2023 | ||||
Seed | Jan 30, 2023 |
Disrupt Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arquimedes Accelerator | Accelerator |
| Agencia Estatal de Investigación | Grant |
| Inveready | VC Round |
| Pompeu Fabra University | Seed |
| University of Barcelona | Seed |
| Center for Technological Development and Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 19, 2025
$380K grant received from Center for Technological Development and Innovation.
- Oct 15, 2024
$79K grant received from Agencia Estatal de Investigación
Disrupt Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Disrupt Therapeutics's valuation, stock price, and market status.